Literature DB >> 29265918

Complex of TNF-α and Modified Fe3O4 Nanoparticles Suppresses Tumor Growth by Magnetic Induction Hyperthermia.

Peishan Teo1, Xiaowen Wang2, Benke Chen1,3, Han Zhang1,4, Xin Yang1,3, Yun Huang1, Jintian Tang1.   

Abstract

BACKGROUND: Magnetic nanoparticles are increasingly applied in clinical area for drug delivery, also in magnetic induction hyperthermia (MIH), and so on. The present research would prepare appropriately modified superparamagnetic iron oxide nanoparticles (SPIONs) to conduct MIH and transfect the anticancer cytokine TNF-α into cells.
MATERIALS AND METHODS: The SPIONs were surface-modified by 3-aminopropyltriethoxysilane (APTS) and/or protamine sulfate (PRO). The combined MIH using SPIONs and gene therapy were applied to treat Hep G2 cells and tumor model transplanted in nude mice.
RESULTS: The PRO-SPIONs (the surfaces were sequentially modified by APTS and PRO) showed high transfection efficiency for TNF-α gene with no obvious cytotoxicity. It also exhibited great temperature rising performance under alternating current magnetic field. The combined MIH and gene therapy using PRO-SPIONs/TNF-α complex could reduce cell variability of Hep G2 cells and tumor size transplanted in nude mice.
CONCLUSIONS: The PRO-SPIONs efficiently transfect the TNF-α gene into Hep G2 cells. Cells expressed more TNF-α when they were exposed to alternating current magnetic field only once. Combined MIH and gene therapy for treatment in vivo exhibited better effects than MIH or gene therapy alone. The combined MIH and gene therapy is promising in liver cancer treatment.

Entities:  

Keywords:  TNF-α; gene therapy; magnetic induction hyperthermia; superparamagnetic iron oxide nanoparticles

Mesh:

Substances:

Year:  2017        PMID: 29265918     DOI: 10.1089/cbr.2017.2404

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  2 in total

Review 1.  Magnetic Hyperthermia for Cancer Treatment: Main Parameters Affecting the Outcome of In Vitro and In Vivo Studies.

Authors:  Vânia Vilas-Boas; Félix Carvalho; Begoña Espiña
Journal:  Molecules       Date:  2020-06-22       Impact factor: 4.411

Review 2.  Targeting the Blood-Brain Tumor Barrier with Tumor Necrosis Factor-α.

Authors:  Angelo Corti; Teresa Calimeri; Flavio Curnis; Andres J M Ferreri
Journal:  Pharmaceutics       Date:  2022-07-06       Impact factor: 6.525

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.